Published in J Int AIDS Soc on January 12, 2010
HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS (2012) 1.97
Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. J Acquir Immune Defic Syndr (2011) 1.67
Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition. Am J Reprod Immunol (2011) 1.32
HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa. Trop Med Int Health (2012) 1.27
Keeping them in "STYLE": finding, linking, and retaining young HIV-positive black and Latino men who have sex with men in care. AIDS Patient Care STDS (2010) 1.18
Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008. Open AIDS J (2012) 1.11
Treatment as prevention: preparing the way. J Int AIDS Soc (2011) 1.09
Change in sexual activity 12 months after ART initiation among HIV-positive Mozambicans. AIDS Behav (2011) 1.07
AIDS vaccines and preexposure prophylaxis: is synergy possible? AIDS Res Hum Retroviruses (2010) 1.07
Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy. Clin Epidemiol (2013) 1.06
A qualitative study of barriers to enrollment into free HIV care: perspectives of never-in-care HIV-positive patients and providers in Rakai, Uganda. Biomed Res Int (2013) 1.05
Behavioral and biomedical combination strategies for HIV prevention. Cold Spring Harb Perspect Med (2012) 1.03
Carework and caring: A path to gender equitable practices among men in South Africa? Int J Equity Health (2011) 1.02
The Promise of Antiretrovirals for HIV Prevention. Curr Infect Dis Rep (2012) 1.02
Medication-related barriers to entering HIV care. AIDS Patient Care STDS (2012) 0.96
HIV among immigrants living in high-income countries: a realist review of evidence to guide targeted approaches to behavioural HIV prevention. Syst Rev (2012) 0.95
CD4 counts and viral loads of newly diagnosed HIV-infected individuals: implications for treatment as prevention. PLoS One (2014) 0.93
Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in kenya. AIDS Res Treat (2012) 0.92
Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub-Saharan Africa. J Int AIDS Soc (2011) 0.85
Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa. BMC Public Health (2015) 0.85
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res (2011) 0.84
Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation. J Biol Chem (2014) 0.84
Chemoprophylaxis for HIV prevention: new opportunities and new questions. J Acquir Immune Defic Syndr (2010) 0.82
Traditional health practitioners' perceptions, herbal treatment and management of HIV and related opportunistic infections. J Ethnobiol Ethnomed (2014) 0.79
Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds. Bioconjug Chem (2011) 0.79
'I am doing fine only because I have not told anyone': the necessity of concealment in the lives of people living with HIV in India. Cult Health Sex (2015) 0.78
Antiretroviral-based HIV prevention strategies for women. Expert Rev Anti Infect Ther (2010) 0.78
Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries. J Infect Dis (2013) 0.78
Pretreatment HIV-1 drug resistance is strongly associated with virologic failure in HIV-infected patients receiving partly active antiretroviral regimens. Future Microbiol (2012) 0.75
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med (2009) 28.62
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet (2008) 11.20
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet (2006) 11.06
Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS (2006) 9.45
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ (2009) 6.03
Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ (1992) 5.66
Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr (2005) 4.96
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One (2009) 4.52
When to start antiretroviral therapy in resource-limited settings. Ann Intern Med (2009) 4.31
Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis (2004) 4.17
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS (2009) 4.07
Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS (2009) 3.91
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis (2002) 3.58
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med (2009) 3.42
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. J Infect Dis (2008) 3.35
Achievements in public health. Reduction in perinatal transmission of HIV infection--United States, 1985-2005. MMWR Morb Mortal Wkly Rep (2006) 3.27
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis (2008) 2.96
Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS (2002) 2.74
Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain). J Acquir Immune Defic Syndr (2008) 1.68
Preventing HIV transmission with antiretrovirals. Bull World Health Organ (2009) 1.50
Couples at risk: HIV-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda. J Acquir Immune Defic Syndr (2005) 1.36
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31
HIV/AIDS. The great funding surge. Science (2008) 1.11
Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges. Clin Exp Immunol (2008) 1.09
When to start antiretroviral therapy--ready when you are? N Engl J Med (2009) 0.93
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet (2006) 11.06
An open letter to The BMJ editors on qualitative research. BMJ (2016) 7.49
Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis (2002) 6.73
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
Tuberculosis. Lancet (2003) 6.39
Rapid expansion of the health workforce in response to the HIV epidemic. N Engl J Med (2007) 6.34
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet (2006) 5.98
Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med (2009) 5.93
Global incidence of multidrug-resistant tuberculosis. J Infect Dis (2006) 5.42
The international Ebola emergency. N Engl J Med (2014) 5.35
Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years. Trop Med Int Health (2003) 4.29
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10
Investment in HIV/AIDS programs: does it help strengthen health systems in developing countries? Global Health (2008) 4.10
The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82
Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature (2006) 3.72
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet (2002) 3.67
The reemerging HIV/AIDS epidemic in men who have sex with men. JAMA (2007) 3.47
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44
Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health (2008) 3.32
Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn (2007) 3.31
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med (2004) 3.26
Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr (2004) 3.19
An integrated physical and genetic map of the rice genome. Plant Cell (2002) 3.07
To retain or remove user fees?: reflections on the current debate in low- and middle-income countries. Appl Health Econ Health Policy (2006) 3.06
Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991-1998. AIDS (2002) 2.97
West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96
Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science (2003) 2.83
HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis (2006) 2.82
National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines? AIDS (2006) 2.82
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A (2009) 2.78
Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med (2011) 2.74
Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med (2011) 2.72
Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med (2015) 2.71
Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis (2002) 2.60
HIV prevalence and associated risk factors among individuals aged 13-34 years in Rural Western Kenya. PLoS One (2009) 2.54
HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA (2006) 2.51
Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ (2005) 2.50
Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis (2003) 2.49
Tuberculosis among health care workers. Emerg Infect Dis (2011) 2.49
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis (2006) 2.48
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res (2011) 2.45
Possible sexual transmission of Ebola virus - Liberia, 2015. MMWR Morb Mortal Wkly Rep (2015) 2.45
Tuberculosis control in the era of HIV. Nat Rev Immunol (2005) 2.40
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis (2010) 2.38
The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. Am J Clin Pathol (2009) 2.34
Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries. J Acquir Immune Defic Syndr (2010) 2.33
Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One (2008) 2.31
Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. PLoS One (2010) 2.30
The Academy of Medical Royal Colleges' statement on clinical research in the UK. Lancet (2009) 2.23
A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol (2009) 2.20
Why older people do not participate in leisure time physical activity: a survey of activity levels, beliefs and deterrents. Age Ageing (2004) 2.20
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Ebola virus disease in the Democratic Republic of Congo. N Engl J Med (2014) 2.19
RNA editing in the human ENCODE RNA-seq data. Genome Res (2012) 2.18
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS (2013) 2.17
Ebola virus disease among children in West Africa. N Engl J Med (2015) 2.17
Antiretroviral therapy in the private sector of Nairobi, Kenya: a review of the experience of five physicians. AIDS (2003) 2.13
What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world? Curr HIV Res (2007) 2.12
Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS (2003) 2.11
Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC Public Health (2005) 2.09
Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med (2005) 2.03
Ebola virus disease cases among health care workers not working in Ebola treatment units--Liberia, June-August, 2014. MMWR Morb Mortal Wkly Rep (2014) 2.02
Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15-64 years in Kenya: results from a nationally representative study. J Acquir Immune Defic Syndr (2014) 2.00
Environmental fate of alkylphenols and alkylphenol ethoxylates--a review. Environ Int (2002) 1.99
Socio-demographic characteristics and behavioral risk factors of female sex workers in sub-saharan Africa: a systematic review. AIDS Behav (2012) 1.99
Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis (2002) 1.97
Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens. AIDS (2007) 1.94
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. Bull World Health Organ (2009) 1.91
Elimination of cholera transmission in Haiti and the Dominican Republic. Lancet (2012) 1.91
Spatial analysis of tuberculosis cases in migrants and permanent residents, Beijing, 2000-2006. Emerg Infect Dis (2008) 1.91
The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission. J Acquir Immune Defic Syndr (2013) 1.85
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS (2010) 1.83